ADMA Biologics
ADMA
#3039
Rank
A$6.31 B
Marketcap
$26.67
Share price
-4.36%
Change (1 day)
186.12%
Change (1 year)

Earnings for ADMA Biologics (ADMA)

Earnings in 2024 (TTM): A$0.13 Billion

According to ADMA Biologics 's latest financial reports the company's current earnings are A$0.38 Billion. In 2023 the company made an earning of -A$5.07 Million, an increase over its 2022 earnings that were of -A$73.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ADMA Biologics from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.13 B-2757.38%
2023 -A$5.07 Million-93.11%
2022 -A$73.53 Million-20.42%
2021 -A$92.41 Million-8.11%
2020 -A$0.11 Billion62.31%
2019 -A$61.96 Million-34.76%
2018 -A$94.98 Million48.79%
2017 -A$63.83 Million134.28%
2016 -A$27.25 Million7.12%
2015 -A$25.44 Million0.3%
2014 -A$25.36 Million7.85%
2013 -A$23.52 Million71.04%
2012 -A$13.75 Million28864%
2011 -A$0.05 Million35.22%
2010 -A$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.42 Billion-390.36%๐Ÿ‡บ๐Ÿ‡ธ USA
A$30.31 M-78.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$41.9 Million-129.31%๐Ÿ‡บ๐Ÿ‡ธ USA